Disease mechanisms in myofibrillar myopathy (MFM): Myofibrillar myopathy caused by dominant mutations in the Z-disc associated LIM Domain Binding protein 3 (LDB3) is a prominent distal myopathy defined by the Z-disc disruption, dissolution of actin filaments and accumulations of degraded myofibrillar proteins in the sarcoplasm of muscle fibers. Mutations in at least 8 other Z-disc associated proteins cause a similar muscle pathology indicating shared disease mechanism for this group of myopathies. The disease mechanisms underlying these pathological changes are not yet known. We generated knock-in mice harboring the most common disease -causing mutation p.A165V in mouse Ldb3 gene. These mice reproduce hallmark features of myofibrillar myopathy. (manuscript in submission). Both heterozygous and homozygous mice develop a similar progressive myopathy indicating a toxic gain-of-function by the mutant protein. Currently, we are testing therapeutic drugs for reversal or stabilization of pathology. We anticipate that these preclinical studies will ultimately translate in patients during future clinical trials. There is a growing interest from patient community to develop therapeutics for MFM. Patient studies: We began the data analysis of 113 patients participated across 6 sites (24 patients at NIH CC) for all 3 study visits in the myotonic dystrophy (DM) clinical research network study (DMCRN; 2014-N-132). We completed the data analysis of the ankle dorsiflexion strength and myotonia measurements in 24 NIH participants (2014-N-0132) by the ankle intellistretch device (developed at the NIH). We enrolled age-and gender matched healthy participants for comparison (n = 5, target n = 10). We developed novel handgrip relaxometer devices to measure hand grip myotonia and conducted a pilot study to characterize and validate the devices in 20 DM1 patients and 10 healthy participants (2014-N-0132). data analysis. is complete (manuscript in draft stage) We got PIRC and IRB approval of a new clinical protocol titled,Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type 1 and Type 2 (ASCEND-DM) (2018-T-N-4295). MFM patients with LDB3 p.A165V mutation have been enrolled for a longitudinal follow up study. We completed exome analysis of about 50 patients with rare undiagnosed neurodegenerative neuromuscular diseases seen in the Neurogenetics Clinic (2000-N-0043) and identified novel mutations, atypical phenotypes and very rare but potentially treatable hereditary neurodegenerative diseases (manuscript in draft stage).

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Todd, Joshua J; Razaqyar, Muslima S; Witherspoon, Jessica W et al. (2018) Novel Variants in Individuals with RYR1-Related Congenital Myopathies: Genetic, Laboratory, and Clinical Findings. Front Neurol 9:118
Jerath, Nivedita U; Mankodi, Ami; Crawford, Thomas O et al. (2018) Charcot-Marie-Tooth Disease type 4C: Novel mutations, clinical presentations, and diagnostic challenges. Muscle Nerve 57:749-755
Watts, Norman R; Zhuang, Xiaolei; Kaufman, Joshua D et al. (2017) Expression and Purification of ZASP Subdomains and Clinically Important Isoforms: High-Affinity Binding to G-Actin. Biochemistry 56:2061-2070
Kovacs, William; Hsieh, Nathan; Roth, Holger et al. (2017) Holistic segmentation of the lung in cine MRI. J Med Imaging (Bellingham) 4:041310
Mankodi, Ami; Kovacs, William; Norato, Gina et al. (2017) Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy. Ann Clin Transl Neurol 4:655-662
Mankodi, Ami; Azzabou, Noura; Bulea, Thomas et al. (2017) Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy. Neuromuscul Disord 27:705-714
Gaur, Lasya; Hanna, Alexander; Bandettini, W Patricia et al. (2016) Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy. Ann Clin Transl Neurol 3:948-955
Mankodi, Ami; Bishop, Courtney A; Auh, Sungyoung et al. (2016) Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy. Neuromuscul Disord 26:650-658
Mankodi, Ami; Grunseich, Christopher; Skov, Martin et al. (2015) Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy. Neuromuscul Disord 25:908-12
Mankodi, Ami; Grunseich, Christopher (2015) Toe-extension myotonia in myotonic dystrophy type 1. Neurology 85:203

Showing the most recent 10 out of 18 publications